(Albany, USA) DelveInsight’s “Bunion Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the Bunion market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The Bunion market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Bunion market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Bunion treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Bunion market.
To Know in detail about the Bunion market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bunion Market Forecast
Some of the key facts of the Bunion Market Report:
- The Bunion market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
- In August 2024, PainReform announced that it has successfully identified the most effective delivery method for PRF-110 in bunionectomy procedures. This achievement positions PRF-110 as a leading option for managing post-surgical pain.
- DelveInsight’s estimates indicate that the largest market size for hallux valgus was in the United States, amounting to approximately USD 3 billion in 2023.
- In 2023, conservative treatment accounted for the second-largest revenue share at approximately 40%, while bunionectomy dominated the market with around 60% share across the 7MM.
- Among the EU4 and the UK, Germany reported the highest revenue, approximately USD 700 million, in 2023.
- In 2023, the United States had approximately 60 million diagnosed prevalent cases of hallux valgus.
- In 2023, the total number of gender-specific prevalent cases of hallux valgus in the 7MM was approximately 45 million for males and around 105 million for females.
- Among the EU4 and the UK, Germany reported the highest number of hallux valgus cases, with approximately 20 million cases in 2023.
- In 2023, the number of treated cases of hallux valgus in the United States was approximately 4 million, and this figure is expected to increase during the forecast period.
- Key Bunion Companies: Heron Therapeutics, Lotus Clinical Research, LLC, Cali Pharmaceuticals LLC, Grünenthal GmbH, Heron Therapeutics, Pacira Pharmaceuticals, Inc, Mallinckrodt, Cali Pharmaceuticals LLC, Johnson & Johnson Pharma, Pfizer, Javelin Pharmaceuticals, Baudax Bio, Xanodyne Pharmaceuticals, and others
- Key Bunion Therapies: HTX-034, Ropivacaine, Naropin, Tapentadol, HTX-011A, Liposome bupivacaine, SKY0402, COV155, Analgesic Non Narcotic, Tapentadol (CG5503), valdecoxib, Intranasal Morphine (MNS075), Exparel, N1539, diclofenac potassium (XP21L), and others
- The Bunion epidemiology based on gender analyzed that women are more frequently diagnosed with Hallux Valgus compared to men.
- The Bunion market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Bunion pipeline products will significantly revolutionize the Bunion market dynamics.
Bunion Overview
A bunion (hallux valgus) is a bony bump that forms at the base of the big toe, where it meets the foot. It develops when the big toe pushes against the adjacent toe, causing the joint to misalign and protrude outward. This condition often results from prolonged pressure on the foot, leading to inflammation, pain, and swelling.
Common causes of bunions include genetic predisposition, wearing tight or high-heeled shoes, arthritis, and foot structure abnormalities. Symptoms may range from mild discomfort to severe pain, making walking difficult. Over time, bunions can worsen, leading to stiffness, calluses, and changes in foot shape.
Bunion treatment options vary depending on severity. Conservative measures include wearing wide-toe shoes, using padding, orthotics, or toe spacers, and applying ice for pain relief. Anti-inflammatory medications and physical therapy may also help. In severe cases, surgery (bunionectomy) is performed to realign the joint and remove the bony protrusion.
Preventing bunions involves wearing well-fitted footwear, maintaining a healthy weight, and performing foot exercises to strengthen the toes. Early intervention can help manage symptoms and slow progression, improving overall foot health and mobility.
Get a Free sample for the Bunion Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/bunion-market
Bunion Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Bunion Epidemiology Segmentation:
The Bunion market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:
- Total Prevalence of Bunion
- Prevalent Cases of Bunion by severity
- Gender-specific Prevalence of Bunion
- Diagnosed Cases of Episodic and Chronic Bunion
Download the report to understand which factors are driving Bunion epidemiology trends @ Bunion Epidemiology Forecast
Bunion Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bunion market or expected to get launched during the study period. The analysis covers Bunion market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Bunion Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Bunion Therapies and Key Companies
- HTX-034: Heron Therapeutics
- Ropivacaine: Lotus Clinical Research, LLC
- Naropin: Cali Pharmaceuticals LLC
- Tapentadol: Grünenthal GmbH
- HTX-011A: Heron Therapeutics
- Liposome bupivacaine: Pacira Pharmaceuticals, Inc
- SKY0402: Pacira Pharmaceuticals, Inc
- COV155: Mallinckrodt
- Analgesic Non Narcotic: Cali Pharmaceuticals LLC
- Tapentadol (CG5503): Johnson & Johnson Pharma
- valdecoxib: Pfizer
- Intranasal Morphine (MNS075): Javelin Pharmaceuticals
- Exparel: Pacira Pharmaceuticals, Inc
- N1539: Baudax Bio
- diclofenac potassium (XP21L): Xanodyne Pharmaceuticals
Discover more about therapies set to grab major Bunion market share @ Bunion Treatment Landscape
Scope of the Bunion Market Report
- Study Period: 2020–2034
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Bunion Companies: Heron Therapeutics, Lotus Clinical Research, LLC, Cali Pharmaceuticals LLC, Grünenthal GmbH, Heron Therapeutics, Pacira Pharmaceuticals, Inc, Mallinckrodt, Cali Pharmaceuticals LLC, Johnson & Johnson Pharma, Pfizer, Javelin Pharmaceuticals, Baudax Bio, Xanodyne Pharmaceuticals, and others
- Key Bunion Therapies: HTX-034, Ropivacaine, Naropin, Tapentadol, HTX-011A, Liposome bupivacaine, SKY0402, COV155, Analgesic Non Narcotic, Tapentadol (CG5503), valdecoxib, Intranasal Morphine (MNS075), Exparel, N1539, diclofenac potassium (XP21L), and others
- Bunion Therapeutic Assessment: Bunion current marketed and Bunion emerging therapies
- Bunion Market Dynamics: Bunion market drivers and Bunion market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Bunion Unmet Needs, KOL’s views, Analyst’s views, Bunion Market Access and Reimbursement
To know more about Bunion companies working in the treatment market, visit @ Bunion Clinical Trials and Therapeutic Assessment
Table of Contents
1. Bunion Market Report Introduction
2. Executive Summary for Bunion
3. SWOT analysis of Bunion
4. Bunion Patient Share (%) Overview at a Glance
5. Bunion Market Overview at a Glance
6. Bunion Disease Background and Overview
7. Bunion Epidemiology and Patient Population
8. Country-Specific Patient Population of Bunion
9. Bunion Current Treatment and Medical Practices
10. Bunion Unmet Needs
11. Bunion Emerging Therapies
12. Bunion Market Outlook
13. Country-Wise Bunion Market Analysis (2020–2034)
14. Bunion Market Access and Reimbursement of Therapies
15. Bunion Market Drivers
16. Bunion Market Barriers
17. Bunion Appendix
18. Bunion Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services